Skip to content

Bally's BALY Professional Service Fees Payable

Professional Service Fees Payable at other companies

Esperion Therapeutics logo
Esperion TherapeuticsESPR
$3.02M-29.5%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$775K+59.1%
AZZ logo
AZZAZZ
$1.2M
IDT Corporation logo
IDT CorporationIDT
$6.86M+93.8%
Rumble, Inc. logo
Rumble, Inc.RUM
$7.59M
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$203K-73.9%

Other financials

Income statement

See full
Revenue$755.7M+105%
Operating income$91.6M+5,161%
Net income-$161.9M-569%
EPS (diluted)-$2.69-572%

Balance sheet

See full
Cash & equivalents$653.4M+183%
Total debt$6.8B+23.0%
Total equity$791.3M-0.6%
Total assets$10.9B+45.9%

Cash flow

See full
Operating cash flow-$145.0M-445%
CapEx$38.9M+27.6%
Free cash flow-$183.9M-1,693%

Valuation

See full
Market cap$707.8M+45.9%
Enterprise value$6.88B+18.6%
P/S0.2×-0.1×

Profitability

See full
Operating margin-4.2%-1.4pp
Net margin-25.3%+31.2pp
FCF margin-12%

Returns & leverage

See full
Return on equity-144%-434pp
Debt / equity8.6×+1.7×
Current ratio1.1×+0.4×

Where this comes from

Reported directly by Bally's in its filing.

Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.

The official record: Bally's’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bally's's professional service fees payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bally's's professional service fees payable?
Bally's (BALY) reported professional service fees payable of $46.72M in Q1 2026.
What is the long-term trend for Bally's's professional service fees payable?
Over 2 years (2020 to 2025), Bally's's professional service fees payable has grown at a 432.2% compound annual growth rate (CAGR), from $1.76M to $49.89M.